The framework for market surveillance established by this Regulation should complement and strengthen existing provisions in Community harmonisation legislation relating to market surveillance and the enforcement of such provisions. However, in accordance with the principle of lex specialis, this Regulation should apply only in so far as there are no specific provisions with the same objective, nature or effect in other existing or future rules of Community harmonisation legislation. Examples can be found in the following sectors: drug precursors, medical devices, medicinal products for human and veterinary use, motor vehicles and aviation. The corresponding provisions of this Regulation should not therefore apply in the areas covered by such specific provisions.
Recital 5, Regulation (EC) No 765/2008 of the European Parliament and of the Council of 9 July 2008…
In forcesince 9 Jul 2008cited 1×
Opinion of Advocate General Campos Sánchez-Bordona delivered on 5 May 2022. Iveco Orecchia SpA v APAM Esercizio SpA and Brescia Trasporti SpDecision
5 May 2022 · 62021CC0084